Event Title
Perioperative outcomes of a hydrocortisone protocol after endonasal surgery for pituitary adenoma resection
Start Date
5-27-2021 9:00 AM
End Date
5-27-2021 5:00 PM
Description
Adrenal insufficiency after transsphenoidal resection of pituitary adenoma (PA) can be seen in 1-12% of cases. In PA, the use of postoperative cortisol measurement and supplementation remains controversial. It is unclear whether postoperative cortisol supplementation has a measurable effect on improving outcomes in patients with pituitary adenoma undergoing endoscopic transsphenoidal surgery (ETS). The objective of the study was to evaluate a postoperative steroid treatment protocol in patients with PA undergoing ETS.
Keywords
pituitary adenoma, postoperative steroids, endonasal, protocol
Included in
Perioperative outcomes of a hydrocortisone protocol after endonasal surgery for pituitary adenoma resection
Adrenal insufficiency after transsphenoidal resection of pituitary adenoma (PA) can be seen in 1-12% of cases. In PA, the use of postoperative cortisol measurement and supplementation remains controversial. It is unclear whether postoperative cortisol supplementation has a measurable effect on improving outcomes in patients with pituitary adenoma undergoing endoscopic transsphenoidal surgery (ETS). The objective of the study was to evaluate a postoperative steroid treatment protocol in patients with PA undergoing ETS.
Comments
Presented at the 2021 House Staff Quality Improvement and Patient Safety Conference